Novozymes Current Ratio 2011-2023 | NVZMY
Current and historical current ratio for Novozymes (NVZMY) from 2011 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Novozymes current ratio for the three months ending December 31, 2023 was 1.30.
| Novozymes Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-12-31 |
$1.37B |
$1.05B |
1.30 |
| 2023-09-30 |
$1.38B |
$0.91B |
1.52 |
| 2023-06-30 |
$1.37B |
$1.00B |
1.37 |
| 2023-03-31 |
$1.38B |
$1.03B |
1.35 |
| 2022-12-31 |
$1.31B |
$0.99B |
1.33 |
| 2022-09-30 |
$1.26B |
$0.98B |
1.29 |
| 2022-06-30 |
$1.22B |
$1.02B |
1.20 |
| 2022-03-31 |
$1.26B |
$1.05B |
1.20 |
| 2021-12-31 |
$1.25B |
$0.90B |
1.38 |
| 2021-09-30 |
$1.14B |
$0.70B |
1.63 |
| 2021-06-30 |
$1.15B |
$0.80B |
1.44 |
| 2021-03-31 |
$1.14B |
$0.82B |
1.39 |
| 2020-12-31 |
$1.06B |
$0.64B |
1.66 |
| 2020-09-30 |
$1.03B |
$0.67B |
1.54 |
| 2020-06-30 |
$1.01B |
$0.71B |
1.43 |
| 2020-03-31 |
$1.06B |
$0.69B |
1.53 |
| 2019-12-31 |
$1.06B |
$0.71B |
1.49 |
| 2019-09-30 |
$1.02B |
$0.79B |
1.29 |
| 2019-06-30 |
$1.03B |
$0.81B |
1.27 |
| 2019-03-31 |
$1.03B |
$0.85B |
1.22 |
| 2018-12-31 |
$1.08B |
$0.88B |
1.24 |
| 2018-09-30 |
$1.04B |
$0.80B |
1.30 |
| 2018-06-30 |
$1.03B |
$0.80B |
1.29 |
| 2018-03-31 |
$1.07B |
$0.83B |
1.29 |
| 2017-12-31 |
$0.93B |
$0.70B |
1.34 |
| 2017-09-30 |
$0.99B |
$0.67B |
1.48 |
| 2017-06-30 |
$0.91B |
$0.61B |
1.49 |
| 2017-03-31 |
$0.95B |
$0.65B |
1.48 |
| 2016-12-31 |
$0.95B |
$0.53B |
1.80 |
| 2016-09-30 |
$0.91B |
$0.51B |
1.78 |
| 2016-06-30 |
$0.95B |
$0.53B |
1.80 |
| 2016-03-31 |
$0.92B |
$0.59B |
1.57 |
| 2015-12-31 |
$0.92B |
$0.49B |
1.86 |
| 2015-09-30 |
$0.97B |
$0.57B |
1.71 |
| 2015-06-30 |
$1.02B |
$0.62B |
1.66 |
| 2015-03-31 |
$1.01B |
$0.62B |
1.64 |
| 2014-12-31 |
$1.30B |
$0.70B |
1.86 |
| 2014-09-30 |
$1.41B |
$0.78B |
1.81 |
| 2014-06-30 |
$1.39B |
$0.71B |
1.95 |
| 2014-03-31 |
$1.28B |
$0.62B |
2.06 |
| 2013-12-31 |
$1.02B |
$0.46B |
2.24 |
| 2013-09-30 |
$0.94B |
$0.41B |
2.32 |
| 2013-06-30 |
$0.92B |
$0.52B |
1.79 |
| 2013-03-31 |
$0.95B |
$0.62B |
1.54 |
| 2012-12-31 |
$0.85B |
$0.45B |
1.87 |
| 2012-09-30 |
$0.87B |
$0.55B |
1.59 |
| 2012-06-30 |
$0.84B |
$0.54B |
1.54 |
| 2012-03-31 |
$0.84B |
$0.52B |
1.61 |
| 2011-12-31 |
$0.90B |
$0.44B |
2.03 |
| 2011-09-30 |
$0.96B |
$0.54B |
1.76 |
| 2011-06-30 |
$0.93B |
$0.52B |
1.79 |
| 2011-03-31 |
$0.89B |
$0.55B |
1.61 |
| 2010-12-31 |
$0.99B |
$0.45B |
2.21 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$26.225B |
$2.598B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
